The cost of some cancer medicines remains a major concern for patients and their families. A new government measure is set to change the prices of several medicine brands across India.
The revised prices came into effect on November 9, following action by the National Pharmaceutical Pricing Authority (NPPA).
The government capped trade margins on 137 cancer drugs. According to the latest figures, 76 drug companies reported revised prices for 1,225 medicine formulations.
Prices have been reduced for 1,031 formulations. Around 600 brands reported cuts of more than 50%, while the highest reported reduction was 96.45%.
The government estimates that these changes could help consumers save around ₹3,502 crore every year.
The move aims to make several cancer medicines more affordable. Patients and families can check the revised prices with pharmacies before buying their medicines.
